Rotman Harris 4
4 · Centessa Pharmaceuticals plc · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Rotman Harris
SVP Regulatory Affairs
Transactions
- Tax Payment
Ordinary Shares
2024-02-01$8.19/sh−4,108$33,645→ 66,892 total - Award
Ordinary Shares
2024-02-01+37,500→ 71,000 total - Sale
Ordinary Shares
2024-02-01$8.10/sh−4,267$34,574→ 62,625 total - Award
Share Option (right to buy)
2024-02-01+75,000→ 75,000 totalExercise: $8.01Exp: 2034-02-01→ Ordinary Shares (75,000 underlying)
Footnotes (6)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The shares reported in this transaction represent Restricted Share Units ("RSUs") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in four equal annual installments with the first such annual vesting being on February 1, 2025.
- [F3]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
- [F4]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 20, 2023.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.83 to $8.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F6]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2024.